wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38828713-327FE9D9-8259-4E6C-8DAF-C8306EFC70F7
Q38828713-327FE9D9-8259-4E6C-8DAF-C8306EFC70F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38828713-327FE9D9-8259-4E6C-8DAF-C8306EFC70F7
Molecular monitoring of chronic myeloid leukemia: present and future.
P2860
Q38828713-327FE9D9-8259-4E6C-8DAF-C8306EFC70F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38828713-327FE9D9-8259-4E6C-8DAF-C8306EFC70F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d8096f4144945c29b351a802b039ebaadba77ab
P2860
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.